Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,392 public trials 2,847 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Study of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple Myeloma

NCT01233895

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Sanofi-Aventis Investigational Site Number 250002 Lille, France

Sanofi-Aventis Investigational Site Number 250001 Nantes, France

Sanofi-Aventis Investigational Site Number 250003 Vandœuvre-lès-Nancy, France

Sanofi-Aventis Investigational Site Number 380001 Torino, Italy

View Trial Details

Completed

A Study Comparing Imatinib and Imatinib/Pegylated Interferon in Chronic Myeloid Leukemia

NCT01227356

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations: Bengt Simonsson Uppsala, Sweden

Uppsala University Hospital Uppsala, Sweden

Uppsala University Hospital Uppsala, Sweden

View Trial Details

Completed

Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma

NCT00095680

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)

NCT00689000

Conditions: Acute Myeloid Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +21 more
Locations: Nexus Oncology Ltd Edinburgh, Scotland, United Kingdom

View Trial Details

Completed

An Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML)

NCT01019161

Conditions: Acute Myeloid Leukaemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Research Site Manchester, United Kingdom

View Trial Details

Completed

Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma

NCT00087867

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders

NCT00186576

Conditions: Blood and Marrow Transplant (BMT), Bone Marrow Diseases, Hematologic Diseases, +5 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Educational and Skills Training Program for Parents of Childhood Cancer Survivors Who Have Neurobehavioral Dysfunction

NCT00713505

Conditions: Burkitt Lymphoma, Cancer Survivor, Cognitive/Functional Effects, +28 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

View Trial Details

Completed

Allo BMT in Advanced Leukemia or High Grade Lymphoma

NCT00186290

Conditions: Blood and Marrow Transplant (BMT), Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

NCT00277160

Conditions: Adnexal Diseases, Agranulocytosis, Breast Cancer, +39 more
Locations: Not specified

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions